Life Spine Announces Line Extension of PRO-LINK® Ti Stand-Alone Cervical Spacer System

Wednesday, May 23, 2018

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to the PRO-LINK Ti Stand-Alone Cervical Spacer System for spinal fusions.

PRO-LINK featuring Life Spines OSSEO-LOC™ surface treatment is a low-profile, stand-alone cervical interbody system designed for cervical fusions. The system has experienced great success since inception. Life Spine is pleased to announce 510(K) clearance, adding additional footprint sizes that enhance the ability to treat a wider variety of patient anatomies. “We have experienced great success and recorded explosive growth rates with the system since inception. I’m excited to see further expansion of the cervical portfolio, especially the enhanced footprints within the PRO-LINK Ti System,” said Mariusz Knap, Vice President of Marketing and Business Development.

“The expanded footprint offering of PRO-LINK Ti helps me address a larger patient population by accommodating smaller and female patient anatomy,” said Randall Dryer MD of the Central Texas Spine Institute.